Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PHVS | PATK |
|---|---|---|
| Price | $30.49 | $66.59 |
| Change today | ▼ 2.24% | ▼ 0.85% |
| Market cap | $2.14B | $2.14B |
| Return, 3 months | -11.9% | -23.7% |
| Return, year to date | +9.9% | -37.7% |
| Return, 1 year | +31.1% | -32.2% |
| P/E (TTM) | -10.4 | 15.9 |
| P/B | 6.3 | 1.9 |
| P/E percentile vs own 5y | 13th | 48th |
| Dividend yield | – | 2.72% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +101.1% | +63.7% |
| Analyst buy share | 92% | 88% |
| RSI (14) | 28 | 29 |
| 30-day volatility | 39.3% | 28.0% |
| Max drawdown, 1 year | -21.5% | -53.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
